Missouri Pharmaceutical Association

Missouri Pharmaceutical Association, a tax-exempt nonprofit based in Jefferson City, Missouri, operates as a federal grant recipient, functioning predominantly as a sub-recipient (87% of awards) on state and federal health initiatives rather than as a prime contractor. The organization holds one prime federal grant award and seven sub-grant awards across public health and pharmacy workforce development programs, with total federal dollars obligated at $14.4 million over the past five years.

The organization's federal footprint centers on public health and pharmacy capacity-building work routed through state health agencies and federal health grantor agencies. As prime recipient, Missouri Pharmaceutical Association received a $4.2 million Military Medical Research and Development grant (CFDA 12.420) from the Defense Health Agency, awarded August 1, 2026, to develop a community pharmacy approach to identifying colorectal cancer risk factors, with performance in Jefferson City and completion targeted for July 31, 2030. As a sub-recipient, the organization carries five awards from the Department of Health and Human Services Centers for Disease Control and Prevention and one from the Defense Health Agency, spanning vaccination capacity expansion, pharmacy diabetes self-management education and support, community health worker training for pharmacy technicians, pharmacist tobacco cessation services, and medication therapy services expansion. Representative sub-award work includes a September 2024 assignment from the Missouri Department of Health and Senior Services to recruit and sustain Diabetes Self-Management Education and Support pharmacy suppliers, a June 2024 sub-award to increase coronavirus disease 2019 and other adult vaccination capacity among Missouri pharmacies, and a March 2024 sub-award providing community health worker training to pharmacy technicians for COVID-19 mitigation. Four distinct federal agencies funded the organization's awards: the Centers for Disease Control and Prevention (6 awards), the Defense Health Agency (1 award), and the Missouri Department of Health and Senior Services as pass-through for federal grants (1 award).

Activity is limited and episodic — two awards in 2021, two in 2022, three in 2024, and one in 2026 — with no federal contract vehicle participation or prime contracting exposure. The organization's federal role is specialized to pharmacy workforce development and public health implementation under grant programs, not procurement or contract services.